Login / Signup

Post-treatment level of LDL-C and all-cause mortality in patients with atherosclerotic cardiovascular disease: evidence from real-world setting.

Fan LuoYuxin LinXiaodong ZhangYanqin LiLicong SuShiyu ZhouRuqi XuQi GaoRuixuan ChenZhixin GuoSheng NieXin Xunull null
Published in: European journal of preventive cardiology (2023)
Our findings supported the safety of currently recommended target of LDL-C control and the "lower is better" principle in patients with ASCVD.
Keyphrases
  • cardiovascular disease
  • type diabetes
  • coronary artery disease
  • cardiovascular risk factors
  • cardiovascular events
  • replacement therapy